Search PubMed⌕ Search

Biomedical subjects

J C Ehrhardt

Publications and source records attributed to J C Ehrhardt.

75 records · Page 5Linked to original sources

Reduction of aliasing in modulation transfer function measurements.

The images formed by many radiological systems are difficult to sample at spatial intervals small enough to avoid aliasing in the calculation of the system's modulation transfer function. However, if a system's response can be assumed to be symmetrical, this assumption can be used to effectively double the sampling density and to double the frequency limit before aliasing occurs. To accomplish this, a more complex algorithm is required. In this work, the formula for the calculation of the modulation transfer function from a symmetrical, one-dimensional line spread function is derived and a similar result for a symmetrical, two-dimensional point spread function is presented. The effect of noisy data and errors in the estimation of the offset of the center of the line spread function from a sampling point are investigated by simulation studies. For low noise (relative standard deviation of 1%) and an offset error of no more than 2% or 3% of a sampling interval, reasonable precision is obtained. These conditions appear to be achievable, especially when the noise is Poisson distributed.

Biometry↗

Generation of pseudorandom numbers.

Computational studies requiring the generation of pseudorandom numbers are becoming increasingly common. These include Monte Carlo methodologies and studies which require the addition of "random" noise to more structured data. Although well-established random number generators exist, many of these are not suitable for implementation on micro- or minicomputer systems. An algorithm for an additive generator that can be used on any computer system is described. The performance of this algorithm as implemented on a microcomputer system is discussed. Extensive testing of the statistical behavior of the resulting number sequence was performed. The algorithm appears to be an appropriate one for a variety of applications.

Computers↗

Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases.

PURPOSE: To assess the effectiveness and safety of higher doses of gadoteridol in the MR evaluation of patients with brain metastases. MATERIALS AND METHODS: Thirty-one patients with a clinical suspicion of brain metastases were studied prospectively with gadoteridol, a new, nonionic, low-osmolality contrast agent. Each patient received an initial injection of 0.1 mmol/kg and an additional dose of 0.2 mmol/kg 30 minutes later. Images were obtained before, immediately after, and 10 and 20 minutes after the initial dose. Images also were acquired immediately after the additional dose of gadoteridol. RESULTS: No adverse effects were attributed to the injection of gadoteridol. Four patients' examinations were excluded from analysis because of machine malfunction (two patients) and excessive motion artifact (two patients). Four patients had no detectable metastases. After the additional dose of gadoteridol, there was a marked qualitative improvement in lesion conspicuity and detection. The conspicuity of 80 of 81 lesions was increased in the high-dose studies, and 46 new lesions were detected in 19 of 27 patients. Quantitative image analysis demonstrated a significant increase in normalized mean lesion contrast between the initial-dose and high-dose studies (35 lesions identified in 13 patients, P less than .0001). The additional information gained by high-dose examinations contributed to a potential modification of the treatment in 10 of 27 patients. High-dose examinations increased flow-related artifact in the posterior fossa in 12 of 27 patients. CONCLUSION: Based on our preliminary results, high-dose gadolinium-enhanced MR examinations may have advantages over 0.1 mmol/kg examinations in detecting early and/or small metastases. This may be significant in the management of patients with cerebral metastases.

Adult↗